tirzepatide controindicazioni Nuovo farmaco per l'obesità: la Food and Drug Administration e l'Mhra inglese autorizzano (Eli Lilly) Effetti collaterali del Mounjaro (tirzepatide)
Description
Instruct patients to inform healthcare providers prior to any planned surgeries or procedures if they are taking MOUNJARO
Both drugs share the same GI side effect class: nausea, diarrhea, constipation, and vomiting
Patients on Tirzepatide 15 mg weekly lost an average of 20.9% or 48.6 lb of their body weight after 72 weeks in the Zepbound Study 1 (NCT04184622) compared to placebo patients who lost an average of 3.1% or 7.2 lb
At RxPros, we believe every patient deserves care tailored to their unique needs
